1. HBW Insight
  2. >>Ingredients & Safety

Sabinsa’s Curcumin Complex Reduces Inflammation In Traumatic Brain Injury Patients

 
• By Eileen Francis

Iranian researchers found using 500 mg curcumin complex daily for seven days reduced levels of leptin, which can promote inflammatory response, in patients with traumatic brain injury. In study published in Phytotherapy Research, 28 subjects had an overall 47.1% reduction in leptin.

Sainsa Headquarters

Sabinsa Corp.’s Curcumin C3 Complex could offer a major inflammatory-reduction benefit to traumatic brain injury patients, according to results of a study conducted by researchers from medical schools in Iran.

Among a panel of 62 patients in the double-blind, placebo-controlled and randomized study, daily use of a supplement with 500 mg C3 Complex and 5 mg of Sabinsa’s bioavailability enhancer BioPerine, which promotes absorption, showed a statistically significant decrease

Calling Out Exaggerated Amla Claims In Vitamin C

Sabinsa says competitors are attempting to cash in on growing demand for vitamin C by inaccurately claiming to offer high concentrations of the nutrient derived from amla extract.

The firm analyzed products claiming as much as 25% concentration to isolate vitamin C in the formulations from amla extract, also known as Indian gooseberry, and to trace the origin of the nutrient to fermentation rather than to amla, it said in a 17 June release.

Sabinsa says its experience manufacturing its Saberry amla extract brand with a standardized amount of 10% beta-glucogallin, an alternative antioxidant to ascorbic acid, drew its attention to competitors’ claims. It argues that suppliers should disclose when they blend fermentation-derived vitamin C with amla extract and claim 25% concentration.

The firm also argues it is not economically feasible to isolate and extract vitamin C up to 25% from the raw material alma extract, but other ingredient providers are claiming they are. It says studies have shown that amla isn’t a valid biomarker or a source of high amounts of vitamin C because it doesn’t contain ascorbic acid in consistent amounts and often only in trace quantities

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on HBW Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Ingredients & Safety

Supplementation Unlikely To Help With Hereditary Hair Loss, Says German Agency

 
• By David Ridley

Germany’s Federal Institute for Risk Assessment says that there is "no evidence that people with androgenetic alopecia have special dietary needs or a special nutrient requirement.”

Melatonin And Buccal Acyclovir On German Switch Committee Agenda

 
• By David Ridley

An application for melatonin as an OTC medicine is on the agenda for the next German switch committee meeting, despite the hormone being widely available in food supplements. Acyclovir as a buccal tablet and second-generation antihistamine rupatadine are also up for discussion.

Plenty For Industry To Do As EU Wastewater Directive Faces Legal Challenges

 
• By David Ridley

Engaging with EU member state legislators, stressing the impact of national EPR systems on the accessibility, availability, and affordability of medicines, reformulating products to reduce their financial contribution, and lobbying for expanding the scope of EPR schemes to include other polluting industries are all ways that the European consumer health industry can try and influence the way that the revised Urban Wastewater Treatment Directive is transposed into national legislation, law firm Mason Hayes & Curran explains.

French Agency Proposes Effective EU Ban On CBD In Foods And Cosmetics

 
• By David Ridley

France's food safety regulator ANSES is proposing a reproductive toxicity category 1B classification for CBD under the EU's CLP regulation, which would mean an effective ban on CBD in cosmetics and foods. However, French hemp industry association UIVEC hopes that new evidence coming out of a European Commission review will put the issue to bed before it gets that far.

More from HBW Insight

Over The Counter: Taking Real-World Evidence Seriously, With IQVIA Consumer Health’s Volker Spitzer

 
• By David Ridley

In part 2 of HBW Insight's interview, IQVIA Consumer Health's vice president of global research and development and real-world evidence services, Volker Spitzer, explains how to approach real world evidence so that regulators recognize its validity, in supporting Rx-to-OTC switch applications, for example.

In Blistering Criticism, Health Subcommittee Democrat Warns Of Kennedy’s ‘Toxic Brew’ Plans

 
• By Malcolm Spicer

Trump’s first-term public health appointees “were serious people doing serious work in a bipartisan nature,” but HHS Secretary Robert F. Kennedy and other current presidential advisors “are not serious people,” says Massachusetts’ Jake Auchincloss.

Green Guides Update, FTC Enforcement In ‘Deregulatory’ Environment – BBB National Programs’ Engle During IBA Conference

 
• By Eileen Francis

The FTC’s Green Guides proposed update was expected by the end of the Biden Administration and there’s no indication it will be unveiled soon, says Mary Engle, BBB National Programs Exec VP, Policy. She also discussed the importance of industry self-regulation of artificial intelligence.